Tag #Biotechnology

Showing 25 to 36 of 92 results

elpais.com

🌐 85% Global Worthiness

Jun 16, 16:15

Nutreco's AI-Powered Phytocomplexes: A Sustainable Solution for Animal Agriculture

Nutreco, in Switzerland, uses AI and plant science to develop FitoComplexes, sustainable feed additives improving animal health and reducing environmental impact by optimizing plant metabolite combinations for improved digestibility and immunity, enhancing animal agriculture's sustainability.

Nutreco's AI-Powered Phytocomplexes: A Sustainable Solution for Animal Agriculture

Nutreco, in Switzerland, uses AI and plant science to develop FitoComplexes, sustainable feed additives improving animal health and reducing environmental impact by optimizing plant metabolite combinations for improved digestibility and immunity, enhancing animal agriculture's sustainability.

Progress

56% Bias Score

ShareSaveArticle

Zero Hunger

12345678

Previous 1 of 8 Next

What specific role does AI play in Nutreco's research and development process for FitoComplexes, and how does it improve the efficacy and scalability of their production?

The FitoComplexes are designed to address the growing need for sustainable animal agriculture by improving efficiency and reducing reliance on antibiotics. Nutreco's approach uses AI to analyze over 100 plants, identifying optimal metabolite combinations for specific animal needs, and focusing on minimizing environmental impact through reduced mineral excretion and sustainable cultivation practices.

es.euronews.com

🌐 85% Global Worthiness

Jun 13, 19:13

AI-designed enzymes: Lithuanian scientists revolutionize enzyme engineering

Three Lithuanian scientists created an AI platform, Intelligent Architecture™, to design custom enzymes for various industrial and medical applications, resulting in partnerships with Kirin and ArcticZymes and making them finalists for the Young Inventors Prize 2025.

AI-designed enzymes: Lithuanian scientists revolutionize enzyme engineering

Three Lithuanian scientists created an AI platform, Intelligent Architecture™, to design custom enzymes for various industrial and medical applications, resulting in partnerships with Kirin and ArcticZymes and making them finalists for the Young Inventors Prize 2025.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate impacts of Biomatter's AI-driven enzyme design platform on the pharmaceutical and industrial sectors?

Three Lithuanian scientists, Karpus, Jauniškis, and Rokaitis, have developed an AI-driven platform for designing custom enzymes. Their platform, Intelligent Architecture™, creates entirely new enzymes for specific industrial and medical applications, surpassing limitations of natural enzyme modifications. This innovation has made them finalists for the Young Inventors Prize 2025.

dw.com

🌐 85% Global Worthiness

Jun 12, 19:11

BioNTech to Acquire Curevac for $1.25 Billion

BioNTech, co-founded by Prof. Ugur Sahin and Prof. Ozlem Tureci, will acquire Curevac for $1.25 billion, strengthening its mRNA cancer treatments, with the deal expected to close by late 2025, combining their expertise in mRNA technology.

BioNTech to Acquire Curevac for $1.25 Billion

BioNTech, co-founded by Prof. Ugur Sahin and Prof. Ozlem Tureci, will acquire Curevac for $1.25 billion, strengthening its mRNA cancer treatments, with the deal expected to close by late 2025, combining their expertise in mRNA technology.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the strategic significance of BioNTech's acquisition of Curevac for the global cancer treatment landscape?

BioNTech, a German biotech firm co-founded by Prof. Ugur Sahin and Prof. Ozlem Tureci, offered to acquire its competitor Curevac for approximately $1.25 billion. The deal aims to strengthen BioNTech's mRNA-based cancer treatment capabilities and is expected to close by the end of 2025. Curevac shareholders are projected to own 4-6% of BioNTech after the acquisition.

spanish.china.org.cn

🌐 85% Global Worthiness

Jun 5, 10:14

China Approves First Domestic 9-Valent HPV Vaccine

China approved its first domestically developed 9-valent HPV vaccine, Cecolin 9, ending over a decade of foreign market dominance; the vaccine protects against nine strains of HPV and has shown a favorable safety profile in clinical trials, aligning with China's plan to eliminate cervical cancer by ...

China Approves First Domestic 9-Valent HPV Vaccine

China approved its first domestically developed 9-valent HPV vaccine, Cecolin 9, ending over a decade of foreign market dominance; the vaccine protects against nine strains of HPV and has shown a favorable safety profile in clinical trials, aligning with China's plan to eliminate cervical cancer by ...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of China's approval of its first domestically produced 9-valent HPV vaccine?

China has approved its first domestically developed 9-valent HPV vaccine, Cecolin 9, ending over a decade of foreign market dominance. This vaccine, developed by Xiamen University, offers broader protection against cervical cancer than bivalent vaccines and showed a favorable safety profile in clinical trials.

forbes.com

🌐 90% Global Worthiness

Jun 4, 01:13

Global Summit Spotlights Race to Extend Healthy Lifespans

The Hevolution Global Healthspan Summit 2025 brought together global leaders in science, technology, and policy to address the challenges and opportunities of extending healthy lifespans, showcasing initiatives like Saudi Arabia's fast-track regulatory system and the UK's massive health data project...

Global Summit Spotlights Race to Extend Healthy Lifespans

The Hevolution Global Healthspan Summit 2025 brought together global leaders in science, technology, and policy to address the challenges and opportunities of extending healthy lifespans, showcasing initiatives like Saudi Arabia's fast-track regulatory system and the UK's massive health data project...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How are countries like Saudi Arabia and the UK strategically positioning themselves to lead the global healthspan innovation race?

The summit showcased several key initiatives driving healthspan research: Saudi Arabia's fast-track regulatory system for healthspan innovations, the UK's "Our Future Health" program amassing a massive health data set, and Hevolution's funding and support of research across the entire value chain, from laboratory discovery to clinical trials. These efforts are critical to bridging the gap between promising research and tangible health improvements, accelerating the translation of scientific discoveries into practical applications.

euronews.com

🌐 85% Global Worthiness

Jun 1, 13:11

Colorifix: Bio-Based Dyes Revolutionize Sustainable Fashion

Colorifix, a UK company, uses bioengineered microbes to create natural fabric dyes, reducing chemical pollution by 80% and water usage, and winning a 2023 Earthshot Prize finalist.

Colorifix: Bio-Based Dyes Revolutionize Sustainable Fashion

Colorifix, a UK company, uses bioengineered microbes to create natural fabric dyes, reducing chemical pollution by 80% and water usage, and winning a 2023 Earthshot Prize finalist.

Progress

36% Bias Score

ShareSaveArticle

Clean Water and Sanitation

12345678

Previous 1 of 8 Next

How does Colorifix's technology work, and what are the key challenges the company is addressing in scaling its production?

Colorifix's innovation involves extracting color-producing DNA from natural sources, inserting it into microbes, and using these microbes as "microscopic color factories" to produce dyes. This approach mimics pre-19th-century methods but utilizes modern biotechnology for scalability and efficiency. The company has partnered with fashion brands like Pangaia and Vollebak.

it.euronews.com

🌐 90% Global Worthiness

Jun 14, 01:11

AI-Designed Enzymes: Lithuanian Scientists Revolutionize Enzyme Engineering

Three Lithuanian scientists created an AI platform, Intelligent Architecture™, to design custom enzymes for medical and industrial uses, resulting in a nomination for the European Patent Office's Young Inventors Award 2025 and partnerships with industry leaders like Kirin and ArcticZymes Technologie...

AI-Designed Enzymes: Lithuanian Scientists Revolutionize Enzyme Engineering

Three Lithuanian scientists created an AI platform, Intelligent Architecture™, to design custom enzymes for medical and industrial uses, resulting in a nomination for the European Patent Office's Young Inventors Award 2025 and partnerships with industry leaders like Kirin and ArcticZymes Technologie...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary impact of Biomatter's AI-driven enzyme design platform on the enzyme market and related industries?

Lithuanian scientists Laurynas Karpus, Vykintas Jauniškis, and Irmantas Rokaitis developed an AI-powered platform, Intelligent Architecture™, that designs custom enzymes. This platform, developed through their company Biomatter, surpasses traditional enzyme design by creating entirely new enzymes for specific industrial and medical applications, unlike modifying existing natural enzymes. Their innovation earned them a spot among the top ten Tomorrow Shapers of the European Patent Office's Young Inventors Award 2025.

welt.de

🌐 85% Global Worthiness

Jun 13, 07:12

BioNTech to Acquire CureVac, Boosting Tübingen's Biotech Hub

BioNTech, a Mainz-based pharmaceutical company, plans to acquire its Tübingen-based rival CureVac in a multi-billion euro deal, aiming to expand mRNA-based cancer immunotherapy research and development in Tübingen, strengthening the region's biotech hub and securing high-skilled jobs.

BioNTech to Acquire CureVac, Boosting Tübingen's Biotech Hub

BioNTech, a Mainz-based pharmaceutical company, plans to acquire its Tübingen-based rival CureVac in a multi-billion euro deal, aiming to expand mRNA-based cancer immunotherapy research and development in Tübingen, strengthening the region's biotech hub and securing high-skilled jobs.

Progress

44% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What is the immediate impact of BioNTech's planned takeover of CureVac on Tübingen's biotech sector and Germany's innovation landscape?

BioNTech's planned acquisition of CureVac will strengthen Tübingen's position as a biotech hub, securing high-skilled jobs and boosting mRNA-based cancer immunotherapy research and development. The deal, expected to be worth billions, follows BioNTech's success with a COVID-19 vaccine while CureVac's efforts were unsuccessful.

forbes.com

🌐 90% Global Worthiness

Jun 10, 13:15

AlphaFold 3: Enhanced Protein Modeling Accelerates Drug Discovery

AlphaFold 3, a new protein modeling tool developed by DeepMind, improves upon its predecessor by expanding its capabilities to include ligands, ions, and post-translational modifications, leading to more accurate predictions and faster drug development; its open-source nature (with some limitations)...

AlphaFold 3: Enhanced Protein Modeling Accelerates Drug Discovery

AlphaFold 3, a new protein modeling tool developed by DeepMind, improves upon its predecessor by expanding its capabilities to include ligands, ions, and post-translational modifications, leading to more accurate predictions and faster drug development; its open-source nature (with some limitations)...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key improvements in AlphaFold 3 compared to its predecessor, and how do these advancements impact drug discovery?

AlphaFold 3, an advanced protein modeling tool, expands upon its predecessor by predicting the structures of ligands, ions, and post-translational modifications, resulting in enhanced accuracy and broader applications in drug discovery. Its reformed Pairformer architecture improves prediction speed and precision.

forbes.com

🌐 85% Global Worthiness

Jun 5, 01:11

World's First Bio-Computer Now Available for $35,000

Cortical Labs is selling the CL1, a $35,000 biological computer containing 800,000 human brain cells on a silicon chip; its potential applications include medical research and AI development, but its short lifespan (up to six months) poses challenges.

World's First Bio-Computer Now Available for $35,000

Cortical Labs is selling the CL1, a $35,000 biological computer containing 800,000 human brain cells on a silicon chip; its potential applications include medical research and AI development, but its short lifespan (up to six months) poses challenges.

Progress

44% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

What is the immediate impact of the CL1's commercial availability on the fields of AI research and drug discovery?

Cortical Labs is selling the world's first commercially available biological computer, the CL1, for $35,000. This device uses 800,000 human brain cells cultured on a silicon chip and allows scientists to directly deploy code to these neurons. The cells are expected to live for up to six months.

smh.com.au

🌐 85% Global Worthiness

Jun 3, 01:13

Chinese Biotech Firm's Lung Cancer Breakthrough Shakes Up Global Pharma Industry

Akeso, a Chinese biotech firm, surprised the world by decisively beating Merck's leading lung cancer drug in clinical trials, marking a significant shift in global pharmaceutical innovation from the US to China, attracting major investments and raising concerns in the US.

Chinese Biotech Firm's Lung Cancer Breakthrough Shakes Up Global Pharma Industry

Akeso, a Chinese biotech firm, surprised the world by decisively beating Merck's leading lung cancer drug in clinical trials, marking a significant shift in global pharmaceutical innovation from the US to China, attracting major investments and raising concerns in the US.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of the shifting global landscape of pharmaceutical innovation, particularly considering the potential impact on US research hubs and job creation?

The increasing number of clinical trials in China, coupled with faster regulatory approvals and a business-friendly environment, is attracting significant multinational investment. This trend could lead to a shift in global pharmaceutical innovation, potentially impacting US dominance and research hubs like Boston's Kendall Square.

arabic.cnn.com

🌐 75% Global Worthiness

May 31, 19:10

Extinct Flower Scents Recreated Using DNA Sequencing

Future Society, a Dubai-based biotechnology company, recreated the scents of six extinct flowers using DNA sequencing of preserved samples from Harvard University Herbarium, collaborating with Ginkgo Bioworks; the resulting perfumes are a blend of natural, synthetic, and bioengineered ingredients, c...

Extinct Flower Scents Recreated Using DNA Sequencing

Future Society, a Dubai-based biotechnology company, recreated the scents of six extinct flowers using DNA sequencing of preserved samples from Harvard University Herbarium, collaborating with Ginkgo Bioworks; the resulting perfumes are a blend of natural, synthetic, and bioengineered ingredients, c...

Progress

36% Bias Score

ShareSaveArticle

Responsible Consumption and Production

12345678

Previous 1 of 8 Next

How has Future Society's use of DNA sequencing revolutionized the perfume industry, and what specific implications does this hold for the future of fragrance creation?

Future Society, a biotechnology perfume company, has successfully recreated the scents of six extinct flowers using DNA sequencing technology. This was achieved in collaboration with Harvard University Herbarium and Ginkgo Bioworks, analyzing preserved plant samples some over 150 years old. The resulting perfumes offer unique woody and floral fragrances previously unavailable.

Showing 25 to 36 of 92 results